e-learning
resources
Munich 2006
Sunday 03.09.2006
Screening, diagnosis, staging, prognosis, biological features
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular markers in non-small cell lung carcinoma
B. T. Ilievska Poposka, G. K. Petrusevska, B. Dimova, S. A. Atanasova, S. Z. Talevski, S. Smickova, T. Stefanovski (Skopje, Fyrom)
Source:
Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Session:
Screening, diagnosis, staging, prognosis, biological features
Session type:
E-Posters in free access
Number:
587
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. T. Ilievska Poposka, G. K. Petrusevska, B. Dimova, S. A. Atanasova, S. Z. Talevski, S. Smickova, T. Stefanovski (Skopje, Fyrom). Molecular markers in non-small cell lung carcinoma. Eur Respir J 2006; 28: Suppl. 50, 587
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Ki-67 in non-small cell lung cancer
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Soluble non-invasive markers in non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005
Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Biological therapies in nonsmall cell lung cancer
Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Year: 2017
Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
Gene modules in non-small cell lung cancer
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
Differential cytokine expression in non-small cell lung carcinomas
Source: Eur Respir J 2007; 30: Suppl. 51, 512s
Year: 2007
Management of EGFR mutated nonsmall cell lung carcinoma patients
Source: Eur Respir J 2015; 45: 1132-1141
Year: 2015
An analysis of EGFR expression and tumour imaging in non-small cell carcinomas of lung
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012
Update on nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 173-185
Year: 2010
The comparison of clinical and pathological stages of the non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 89s
Year: 2006
Role of chemokines in resectable non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Second line therapy for advanced non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016
A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Characteristics and survival analysis of synchronous oligometastatic non-small cell lung carcinoma.
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Clinical features of nonsmall cell lung cancer cases
Source: Eur Respir J 2002; 20: Suppl. 38, 75s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept